A Built-In CpG Adjuvant in RSV F Protein DNA Vaccine Drives a Th1 Polarized and Enhanced Protective Immune Response
Work
Year: 2018
Type: article
Abstract: Human respiratory syncytial virus (RSV) is the most significant cause of acute lower respiratory infection in children. However, there is no licensed vaccine available. Here, we investigated the effec... more
Source: Viruses
Cites: 54
Cited by: 27
Related to: 10
FWCI: 2.353
Citation percentile (by year/subfield): 90.5
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Sustainable Development Goal Good health and well-being
Open Access status: gold
APC paid (est): $2,815